Kangfu Anti-inflammatory Suppository

Developed for: pelvic inflammatory disease
Investigated by: Beijing Obstetrics and Gynecology Hospital · Chengdu University of Traditional Chinese Medicine · China Academy of Chinese Medical Sciences · First Affiliated Hospital of Heilongjiang Chinese Medicine University · Longhua Hospital · Peking Union Medical College Hospital
+5 more
· Peking University First Hospital · Peking University Third Hospital · Shenzhen Maternal and Child Health Hospital · The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine · Xiyuan Hospital of China Academy of Chinese Medical Sciences

today NCT04035785 · Ph 4

2020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT04035785	Jul 2019	pelvic inflammatory disease	China Academy of Chinese Medical Sciences	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Kangfu Anti-inflammatory Suppository	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04035785 ↗